Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group Plc LSE:DEMG London Ordinary Share GB0059337583 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 1.15 40,000 01:00:00
Bid Price Offer Price High Price Low Price Open Price
1.10 1.20 1.15 1.15 1.15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 2.26 -0.98 -0.17 8
Last Trade Time Trade Type Trade Size Trade Price Currency
10:43:55 O 15,000 1.10 GBX

Deltex Medical (DEMG) Latest News

More Deltex Medical News
Deltex Medical Investors    Deltex Medical Takeover Rumours

Deltex Medical (DEMG) Discussions and Chat

Deltex Medical Forums and Chat

Date Time Title Posts
28/6/202209:24Deltex Medical - a British success story!11,707
07/4/202215:50Deltex Medical-Optimal Growth Stock10,017
07/4/202207:52Deltex Medical - winner or doomed to fail? 417
22/3/201209:04Deltex Medical - Past, Present and Future-
07/12/201111:57Deltex Medical - More key endorsements-

Add a New Thread

Deltex Medical (DEMG) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2022-07-01 09:43:561.1015,000165.00O
2022-07-01 09:13:531.1025,000275.00O
View all Deltex Medical trades in real-time

Deltex Medical (DEMG) Top Chat Posts

Deltex Medical Daily Update: Deltex Medical Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker DEMG. The last closing price for Deltex Medical was 1.15p.
Deltex Medical Group Plc has a 4 week average price of 1.15p and a 12 week average price of 1p.
The 1 year high share price is 1.85p while the 1 year low share price is currently 1p.
There are currently 699,063,796 shares in issue and the average daily traded volume is 14,273 shares. The market capitalisation of Deltex Medical Group Plc is £8,039,233.65.
gavapentin: Too quick to score points - I think that was you! Please note....editorials do not have a "Discussion" at the end....but then as an expert, you would well know that. Thus there was never any need to reference it ;) Also you suggest DrEaMing is an outcome not a process....the data actually points to the latter. There are none so blind as those over invested. As I know to my cost in other stocks. DEMG is not a bad stock. But even with a major player, it is unlikely to make RAPID reversals of fortune. I will await the apology from TC with baited breath lmao - too chippy/overinvested to ever recognise others opinions have validity
schloo: Ah Gavapentin, you got me there! So, turns out there are two DREAM papers in the BJA and you meant the FREE one: shame you were too lazy to give any sort of reference in your original rush to troll but well done for feeling you earned the right to score a cheap shot Nobody is disagreeing that the evidence is contested: but, back in the day, contesting the evidence did not mean the earth was not round and that it did not orbit the sun The DREAM concept is simple, elegant and potentially powerful. If a patient is able to drink, eat and move around the day after major surgery they will normally do a lot better than those who cannot. This is not really that novel, is it? If you ring the ward to ask how someone is getting on after an op, it is always good to hear that they have got up and are sitting in a chair having a cup of tea and a biscuit Of course, those who have studied the ODM evidence base will point out that patients whose fluids were optimised using ODM during surgery are more rather than less likely to be able to drink, eat and move around the day after surgery than those whose fluids were managed using lesser or no technology guidance If you want to know more about where the DREAM (DRinking EAting Mobilising) concept comes from, try looking at the cartoon on the & note that the home page is headed 'Preoperative Fluid Management'. Monty M, the leader of this is also one of the authors of the new PQIP study The CHEERS acronym is a bit ugly, but C is for carbohydrate loading (not hungry), H is for hydrated (not thirsty) and the first E for euvolemic (the right amount of fluid). So it is all about fluid management and if you do this plus the other E (right amount of salt) you are on track to get a DREAMing patient The whole point of the DREAM campaign is to get more people using ODM in line with the (uncontestable?) evidence base My point is that mega company marketing is needed to make this happen because medical science has not been able to do the job. That ought to be sad for everyone and not just those who have lost a lot of money on DEMG backing the evidence and ought to be a source of profound shame to the flat-earthers
schloo: >>Gavapentin Seriously? Is that pathetic distortion the best you have got? 1. I'm not going to pay to read an editorial just because of some troll, but the thrust of the piece is obviously supportive of what DEMG have been trying to achieve for years 2. Of course the evidence for goal directed fluid optimisation remains contested. Otherwise it would be enforced as a standard of care across the world 3. There is only one author on this paper, Prof Henrik Kehlet. Spoke to him earlier this year and he categorically does not contest the evidence for goal directed fluid optimisation guided by DEMG's Doppler technologies. He is just very frustrated that so many people can't be bothered with evidence based best practice 4. As highlighted by the Count there are lots of studies with the Edwards & Lidco technologies but they simply can not deliver the same results as DEMG's Doppler. Perhaps that is because they measure completely different things in different ways in different places 5. Conflating PPWA with Doppler has caused confusion, whether due to lack of intellectual rigour or bias or industry affiliation related bias. Fluid optimisation during surgery is highly effective with Doppler but not with PPWA 6. However the choices remain stark: make Doppler happen or carry on wasting lives and money No idea why you are so anti-DEMG. No idea how you live with yourself for tolerating routine delivery of second rate & harmful care DEMG have not been able to change your mind, nor has probably the most robust evidence base for any anaesthetic protocol/intervention anywhere ever, nor the myriad of experts who have wasted years trying to lead their colleagues to improve care. This is why DEMG need to sell to a major who can persuade with marketing where medical science has failed Hope you are still young enough to see the light at a ski 'meeting' or some such activity generously supported with an 'unrestricted educational grant' from DEMG's next owners
schloo: I did not go to the AGM but thought the update was good news. There are signs of volumes picking up and they have a new monitor pretty much ready to go which incorporates a non-invasive Doppler offer which, in itself, could be a world-beater. As a reminder, the current box was launched in 1999 and has been way too tired to sell many of for years & years. But the market, including the US, is happy to buy more modern newer monitors, even if they do not run anything like as good medical techs as the DEMG ones They do not have to sell many monitors to double the total sales in H2 over last year and, in my view, ought to be looking to sell to a major strategic company the moment they can point to sales traction. Share price should rise sharply on sales growth and then up again for a control premium Doing the above is straight out of the LidCo playbook. LidCo ceased the opportunity going into CoVid and DEMG needs to seize it coming out 6p exit ought to be easily doable from here I agree that there are strong arguments for refreshing the board. Doing so now could easily increase the exit price by a third or a half, so maybe up to 10p. I would much rather get 10p than 6p. But radical change in Board membership just isn't going to happen given the characters involved. That was very clear from putting Cazalet up for a seat yet again, so not sure there is much point in wasting breath calling for change Will buy some more at least up to 2.5p as & when find some investment cash
gbenson1: Hi mrC2u, I've been in DEMG shares for forever, they never seem to be bullish in any of their communicates, which has held the company back. I agree we need a infusion of fresh younger blood on the board which has become stale/set in its ways..
mrc2u: Just read small print and see the DEMG AGM is tomorrow morning. Proper companies announce the date separately. I know that because I am going to a proper company's AGM tomorrow morning...Anyone clock this and actually able to go?MrC
maxk: Cool beans.. The Board has concluded that it is now appropriate to raise a total of approximately GBP1.4 million by way of subscription for 111,720,000 Subscription Shares at a price of 1.25 pence per Deltex Medical ordinary share ("Share"). This represents a 9% discount to the closing mid-market Share price on 07 February 2022. Certain directors of the Company, namely Nigel Keen, Julian Cazalet, Mark Wippell, Natalie Wettler and Andy Mears, intend to participate in the Subscription for, in aggregate, 32,610,400 new Shares at the Issue Price.
mrc2u: Well, well, well at long last DEMG has got on with one of the basics needed to revive the share price and it has appointed new advisersSadly not due to dynamic action by the sleeping Board though but because the incumbent has been suspended. Oh and there is some, small?, risk of delisting. Wakey wakeyMrC
bigt20: The Count10 Feb '22 - 17:41 - 11642 of 11648 If you remember sometime ago it was suggested that they should have a listing in the US but they were not keen on it. Hopefully when things pick up later this year (and hopefully the share price) I think they should have a serious look at a US listing as I believe this company would get a far better rating over there.
nobbygnome: Yes should be good news for DEMG share price as it will show the true value of a business like this!
Deltex Medical share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Deltex Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220702 02:21:38